Back to Results
First PageMeta Content
Tissue plasminogen activator / Thrombolysis / Stroke / Thrombolytic drug / Aspirin / Desmoteplase / Deep vein thrombosis / Myocardial infarction / Thrombosis / Medicine / Health / Aging-associated diseases


Expansion of the Time Window for Treatment of Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator: A Science Advisory From the American Heart Association/American Stroke Association Gregory J. del Zoppo,
Add to Reading List

Document Date: 2009-12-30 17:02:07

Open Document

File Size: 367,93 KB

Share Result on Facebook

City

Dallas / Baltimore / Greenville / Heidelberg / /

Company

Wolters Kluwer / American Heart Association Inc. / Risk Factor Management / Genentech / Ford / Talecris / nFocus* WL Gore & Associates / HP / /

Country

Germany / /

Currency

USD / /

/

Event

FDA Phase / /

Facility

Associates† None Philip Gorelick University of Illinois None None BoehringerIngelheim† None None Genentech* None Pooja Khatri University / University of Iowa / Advisory Board Other Gregory J. del Zoppo University of Washington None None None None None None Harold P. Adams / Cochrane/National Institute of Neurological Disorders / National Institute of Neurological Disorders / Jr University of Iowa Grant / University None Genentech* None Genentech* nFocus* WL Gore / Cincinnati NIH K23† None None None None None None Tanya Turan Medical University of South Carolina NIH/NINDS / AHA National Center / Novo Nordisk* None None Genentech* None Jeffrey L. Saver University of California at Los Angeles Boehringer Ingelheim* Concentric* Concentric Medical* / /

/

IndustryTerm

online version / Stroke Treatment / treatment of stroke / stroke care / /

MedicalCondition

acute hemispheric stroke / intracranial hemorrhage / early stroke / ischemic stroke / rt-PA stroke / intracerebral hemorrhage / Symptomatic intracranial hemorrhage / acute ischaemic stroke / symptomatic intracerebral hemorrhage / acute stroke / prior myocardial infarction / acute thromboembolic stroke / Atherosclerotic Peripheral Vascular Disease / MS / acute carotid artery territory stroke / malpractice stroke / Stroke / diabetes / diabetes mellitus / deep vein thrombosis / heart failure / acute thrombotic and embolic stroke / thrombus / Acute Ischemic Stroke II / acute ischemic stroke / /

MedicalTreatment

emergency treatment / Thrombolytic Therapy / /

Organization

Hamilton S. Association / Clinical Cardiology Council / University of Washington None None None None None None Harold P. Adams / Coordinating Committee / American Heart Association/American Stroke Association Stroke Council / American Heart Association/American Stroke Association / AHA Task Force on Practice Guidelines / AHA National Center / Executive Committee / Cardiovascular Radiology and Intervention Council / Cochrane/National Institute of Neurological Disorders and Stroke / National Stroke Association / National Institute of Neurological Disorders and Stroke / University of South Carolina NIH / University of Cincinnati / University of Iowa Grant / American Heart Association Stroke Council / American Heart Association / Associates† None Philip Gorelick University of Illinois None None BoehringerIngelheim† None None Genentech* None Pooja Khatri University / University of Iowa / Washington University / University of California at Los Angeles / European Medicines Evaluation Agency / Research Support Speakers’ Bureau / /

Person

Colin Derdeyn / Ann Neurol / Gregory J. del Zoppo / Harold P. Adams / Jeffrey L. Saver / Harold P. Adams / Jr / Edward C. Jauch / /

/

Position

Higashida RT / Consultant / Director / Chair / /

Product

ECASS-3 / /

ProgrammingLanguage

EC / /

ProvinceOrState

Texas / Maryland / California / Iowa / /

PublishedMedium

Lippincott Williams & Wilkins / /

URL

http /

SocialTag